Adam J Santanasto1, Paul M Coen2, Nancy W Glynn1, Kevin E Conley3, Sharon A Jubrias3, Francesca Amati4, Elsa S Strotmeyer1, Robert M Boudreau1, Bret H Goodpaster4, Anne B Newman5. 1. Center for Aging and Population Health, Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, United States. 2. Department of Health and Physical Activity, School of Education, University of Pittsburgh, Pittsburgh, United States. 3. Translational Center for Metabolic Imaging, University of Washington, Seattle, United States. 4. Division of Endocrinology and Metabolism, School of Medicine, University of Pittsburgh, Pittsburgh, United States. 5. Center for Aging and Population Health, Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, United States. Electronic address: newmana@edc.pitt.edu.
Abstract
BACKGROUND: Age related declines in walking performance may be partly attributable to skeletal muscle mitochondrial dysfunction as mitochondria produce over 90% of ATP needed for movement and the capacity for oxidative phosphorylation decreases with age. METHODS: Participants were from two studies: an ancillary to the Lifestyle Interventions and Independence for Elders (LIFE) Study (n=33), which recruited lower functioning participants (Short Physical Performance Battery [SPPB], 7.8±1.2), and the Study of Energy and Aging-Pilot (SEA, n=29), which enrolled higher functioning (SPPB, 10.8±1.4). Physical activity was measured objectively using the Actigraph accelerometer (LIFE) and SenseWear Pro armband (SEA). Phosphocreatine recovery following muscle contraction of the quadriceps was measured using (31)P magnetic resonance spectroscopy and ATPmax (mM ATP/s) was calculated. Walking performance was defined as time (s) to walk 400m at a usual-pace. The cross-sectional association between mitochondrial function and walking performance was assessed using multivariable linear regression. RESULTS: Participants were 77.6±5.3years, 64.2% female and 67.2% white. ATPmax was similar in LIFE vs. SEA (0.52±0.14 vs. 0.55±0.14, p=0.31), despite different function and activity levels (1.6±2.2 vs.77.4±73.3min of moderate activity/day, p<0.01). Higher ATPmax was related to faster walk-time in SEA (r(2)=0.19, p=0.02,); but not the LIFE (r(2)<0.01, p=0.74) cohort. CONCLUSIONS: Mitochondrial function was associated with walking performance in higher functioning, active older adults, but not lower functioning, sedentary older adults.
BACKGROUND: Age related declines in walking performance may be partly attributable to skeletal muscle mitochondrial dysfunction as mitochondria produce over 90% of ATP needed for movement and the capacity for oxidative phosphorylation decreases with age. METHODS:Participants were from two studies: an ancillary to the Lifestyle Interventions and Independence for Elders (LIFE) Study (n=33), which recruited lower functioning participants (Short Physical Performance Battery [SPPB], 7.8±1.2), and the Study of Energy and Aging-Pilot (SEA, n=29), which enrolled higher functioning (SPPB, 10.8±1.4). Physical activity was measured objectively using the Actigraph accelerometer (LIFE) and SenseWear Pro armband (SEA). Phosphocreatine recovery following muscle contraction of the quadriceps was measured using (31)P magnetic resonance spectroscopy and ATPmax (mM ATP/s) was calculated. Walking performance was defined as time (s) to walk 400m at a usual-pace. The cross-sectional association between mitochondrial function and walking performance was assessed using multivariable linear regression. RESULTS:Participants were 77.6±5.3years, 64.2% female and 67.2% white. ATPmax was similar in LIFE vs. SEA (0.52±0.14 vs. 0.55±0.14, p=0.31), despite different function and activity levels (1.6±2.2 vs.77.4±73.3min of moderate activity/day, p<0.01). Higher ATPmax was related to faster walk-time in SEA (r(2)=0.19, p=0.02,); but not the LIFE (r(2)<0.01, p=0.74) cohort. CONCLUSIONS: Mitochondrial function was associated with walking performance in higher functioning, active older adults, but not lower functioning, sedentary older adults.
Authors: Charles E Matthews; Kong Y Chen; Patty S Freedson; Maciej S Buchowski; Bettina M Beech; Russell R Pate; Richard P Troiano Journal: Am J Epidemiol Date: 2008-02-25 Impact factor: 4.897
Authors: Paul M Coen; Sharon A Jubrias; Giovanna Distefano; Francesca Amati; Dawn C Mackey; Nancy W Glynn; Todd M Manini; Stephanie E Wohlgemuth; Christiaan Leeuwenburgh; Steven R Cummings; Anne B Newman; Luigi Ferrucci; Frederico G S Toledo; Eric Shankland; Kevin E Conley; Bret H Goodpaster Journal: J Gerontol A Biol Sci Med Sci Date: 2012-10-09 Impact factor: 6.053
Authors: Catherine A Richardson; Nancy W Glynn; Luigi G Ferrucci; Dawn C Mackey Journal: J Gerontol A Biol Sci Med Sci Date: 2014-09-04 Impact factor: 6.053
Authors: Kevin R Short; Maureen L Bigelow; Jane Kahl; Ravinder Singh; Jill Coenen-Schimke; Sreekumar Raghavakaimal; K Sreekumaran Nair Journal: Proc Natl Acad Sci U S A Date: 2005-03-30 Impact factor: 11.205
Authors: Anne B Newman; Alice M Arnold; Michael C Sachs; Diane G Ives; Mary Cushman; Elsa S Strotmeyer; Jingzhong Ding; Stephen B Kritchevsky; Paulo H M Chaves; Linda P Fried; John Robbins Journal: J Am Geriatr Soc Date: 2009-01-29 Impact factor: 5.562
Authors: I Bourdel-Marchasson; M Biran; P Dehail; T Traissac; F Muller; J Jenn; G Raffard; J M Franconi; E Thiaudiere Journal: J Nutr Health Aging Date: 2007 May-Jun Impact factor: 4.075
Authors: Fatemeh Adelnia; Jacek Urbanek; Yusuke Osawa; Michelle Shardell; Nicholas A Brennan; Kenneth W Fishbein; Richard G Spencer; Eleanor M Simonsick; Jennifer A Schrack; Luigi Ferrucci Journal: J Am Geriatr Soc Date: 2019-05-22 Impact factor: 5.562
Authors: Patrick J Brown; Nicholas Brennan; Adam Ciarleglio; Chen Chen; Carolina Montes Garcia; Stephanie Gomez; Steven P Roose; Bret R Rutherford; Eleanor M Simonsick; Richard G Spencer; Luigi Ferrucci Journal: Am J Geriatr Psychiatry Date: 2019-04-06 Impact factor: 4.105
Authors: Emily Wasson; Andrea L Rosso; Adam J Santanasto; Caterina Rosano; Meryl A Butters; W Jack Rejeski; Robert M Boudreau; Howard Aizenstein; Theresa Gmelin; Nancy W Glynn Journal: Exp Gerontol Date: 2018-12-04 Impact factor: 4.032
Authors: Ryan J Dougherty; Janani Ramachandran; Fangyu Liu; Yang An; Amal A Wanigatunga; Qu Tian; Murat Bilgel; Eleanor M Simonsick; Luigi Ferrucci; Susan M Resnick; Jennifer A Schrack Journal: Alzheimers Dement (Amst) Date: 2021-08-20
Authors: Marta Gonzalez-Freire; Paul Scalzo; Jarod D'Agostino; Zenobia A Moore; Alberto Diaz-Ruiz; Elisa Fabbri; Ariel Zane; Brian Chen; Kevin G Becker; Elin Lehrmann; Linda Zukley; Chee W Chia; Toshiko Tanaka; Paul M Coen; Michel Bernier; Rafael de Cabo; Luigi Ferrucci Journal: Aging Cell Date: 2018-01-21 Impact factor: 9.304
Authors: R M Dodds; K Davies; A Granic; K G Hollingsworth; C Warren; G Gorman; D M Turnbull; A A Sayer Journal: Exp Gerontol Date: 2018-09-25 Impact factor: 4.032
Authors: Baback Roshanravan; Sophia Z Liu; Amir S Ali; Eric G Shankland; Chessa Goss; John K Amory; H Thomas Robertson; David J Marcinek; Kevin E Conley Journal: PLoS One Date: 2021-07-15 Impact factor: 3.240
Authors: Jing Sun; Todd T Brown; David C Samuels; Todd Hulgan; Gypsyamber D'Souza; Beth D Jamieson; Kristine M Erlandson; Jeremy Martinson; Frank J Palella; Joseph B Margolick; Gregory D Kirk; Jennifer A Schrack Journal: Clin Infect Dis Date: 2018-08-16 Impact factor: 20.999